The U.S. Food and Drug Administration on Friday issued an “emergency use authorization” for the drug remdesivir to treat COVID-19 patients, a fast-tracked approval of a drug that early clinical trial results show can speed recovery. In a letter Friday to Gilead Sciences, the California-based drug-maker that owns the rights to the drug, the FDA … Continued
Preliminary results in a clinical trial for the drug remdesivir to treat COVID-19 patients shows promise that the drug is likely “going to be saving lives,” but the drug company will be challenged to make enough for those who’ll need it, said the doctor at the University of Alabama at Birmingham who oversaw the university’s … Continued
The Business Council of Alabama (BCA) today announced that Montgomery-based Medical Place, a BCA member, has donated $100,000 to the University of Alabama at Birmingham (UAB), earmarked for COVID-19 related research. This came after Medical Place approached BCA for help facilitating the donation to a group working on long-term coronavirus relief. “My father’s motto, which … Continued
The University of Alabama at Birmingham is putting six labs to work testing a potential vaccine for COVID-19, the university announced Monday. Scientists at UAB will be conducting preclinical testing on mice of Gaithersburg, Maryland-based Altimmune’s vaccine called AdCOVID. Once that testing is complete the company could begin testing on humans later this year, according … Continued
The University of Alabama at Birmingham has been selected as a site for clinical trials of a drug that could potentially treat hospitalized COVID-19 patients. The National Institute of Allergy and Infectious Diseases chose UAB as one of 75 sites around the world, and enrollment in what is phase three of the clinical trials began … Continued